Taysha Gene Therapies (TSHA)
(Delayed Data from NSDQ)
$2.45 USD
+0.06 (2.51%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $2.46 +0.01 (0.41%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Earnings News For TSHA
-
Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
-
Taysha Gene Therapies Reports Initial Clinical Data from First Adult Rett Syndrome Patient Dosed in REVEAL Phase 1/2 Trial and Provides Corporate Update with Second Quarter 2023 Financial Results
-
Taysha Gene Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
Taysha Gene Therapies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
-
Taysha Gene Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update